Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 6, 2008

View Archived Issues

First clinical data on TH-302 released

Recent Janssen patent divulges novel antiarthritic agents

Anticancer VEGFR/PDGFR tyrosine kinase inhibitor TAK-593 profiled

Pegylated docetaxel demonstrates improved efficacy in xenograft models

Preliminary data reported for ANG-1005 in solid tumors, brain metastases and malignant glioma

AstraZeneca rounds up Q3 activities

NicOx reports favorable blood pressure data for naproxcinod in OA patients

Lytix Biopharma presents preclinical results of novel antibacterial LTX-109

FDA approves Norditropin for children born small for gestational age

Potent antifungal activity shown for a novel sordarin derivative in preclinical testing

Celera and Abbott collaborate to identify pharmacogenomic markers

Mesoblast commences phase I/II allogeneic mesenchymal precursor cell trial

Phase II CERE-110 trial in Alzheimer's disease to be funded by NIH grant

SciClone and Sigma-Tau report phase III HCV trial results with Zadaxin

Therapure Biopharma collaborates with BioVectra

Y's Therapeutics to conduct phase I/II trial of YSCMA in France

Recent Kowa patent reports novel therapeutic agents for lipoprotein disorders

Novel mutilin-quinolone hybrid antibacterial from Kyorin described

Interim data show feasibility of i.v., s.c. PRO-140 for HIV

Complete response submitted to FDA for Sanvar in esophageal bleeding

SurModics acquires drug delivery technology from PR Pharmaceuticals

Invitrogen provides update on merger with Applied Biosystems

Derma Sciences initiates enrollment in phase II study of DSC-127 in diabetic foot ulcers

Sanofi-aventis discontinues rimonabant clinical development

New dopamine/serotonin receptor agonists imparted in recent Atir patent

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 11, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...